This is a non-core endpoint: only basic statistics are computed.
Disorders of purine and pyrimidine metabolism, other/unspecified
E4_PURINEPYRINAS
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
24
Check minimum number of events None
24
Include endpoints None
24
Remove individuals based on genotype QC
24
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Disorders of purine and pyrimidine metabolism, other/unspecified based on the number of shared cases.
Broader endpoints:
- Disorders of purine and pyrimidine metabolism
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Paracetamol of NSAID medication
- Any operation in hilmo
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 24 | 14 | 10 |
Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
Mean age at first event (years) | 55.84 | 53.79 | 58.70 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_PURINEPYRINAS – Disorders of purine and pyrimidine metabolism, other/unspecified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Disorders of purine and pyrimidine metabolism, other/unspecified
↥Endpoint not on priority list, no data to show.